Human Regulatory

The European Commission Health and Consumers Directorate-General (DG SANCO) published a staff working document (SWD) on the use of ‘–omics’ technologies in the development of personalised medicine on 31 October 2013.

The report focuses on

  1. the potential and issues with the use of –omics technologies in the research and development of personalised medicine and current EU research funding in the area;
  2. recent developments in EU legislation for placing medicinal products and medical devices on the market;
  3. factors affecting the uptake of personalised medicine in healthcare systems.

Officials have indicated that the report will not provide policy recommendations and that no legislative review is foreseen.